Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children.
KDIGO 2025 兒童腎病症候群管理臨床實踐指引執行摘要
Kidney Int 2025-04-20
To biopsy or not to biopsy a teenager with typical idiopathic nephrotic syndrome? Start steroids first.
對於典型特發性腎病綜合症的青少年,是否進行活檢?先開始使用類固醇。
Pediatr Nephrol 2024-09-11
A commentary from the European Renal Best Practice (ERBP) on the Kidney Disease Improving Global Outcomes (KDIGO) 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease in children and adults.
歐洲腎臟最佳實踐(ERBP)對於2024年慢性腎病評估與管理臨床實踐指導方針(KDIGO)在兒童和成人中的評論。
Nephrol Dial Transplant 2024-09-19
Steroid pulse therapy in idiopathic nephrotic syndrome in the era of modern immunosuppressive treatment-still up to date?
現代免疫抑制治療時代的特發性腎病綜合症類固醇脈衝療法——仍然是最新的嗎?
Pediatr Nephrol 2024-09-24
Expected and verified benefits from old and new corticosteroid treatments in IgA nephropathy: from trials in adults to new IPNA-KDIGO guidelines.
IgA 腎病中舊有與新型皮質類固醇治療的預期與驗證效益:從成人試驗到新的 IPNA-KDIGO 指南。
Pediatr Nephrol 2025-03-05
Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2024 Clinical Practice Guideline.
慢性腎病的評估與管理:2024年腎病:改善全球結果臨床實踐指導方針摘要。
Ann Intern Med 2025-03-10
Utilization of anti-CD20 antibodies for treatment of childhood nephrotic syndrome, 2010 to 2022.
2010至2022年間抗CD20抗體於兒童腎病症候群治療之應用
Pediatr Nephrol 2025-06-05